Biofrontera Inc. Operating Lease, Payments
Biofrontera Inc. (BFRI) reported Operating Lease, Payments of $300.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Biofrontera Inc. operating lease, payments for fiscal 2025 was $731.00K, a 6.04% decline from fiscal 2024.
- Biofrontera Inc. operating lease, payments for fiscal 2024 was $778.00K, a 6.14% increase from fiscal 2023.
- Biofrontera Inc. operating lease, payments for fiscal 2023 was $733.00K, a 6.15% decline from fiscal 2022.
- Biofrontera Inc. operating lease, payments for fiscal 2022 was $781.00K.
| Period end | Operating Lease, Payments 6 month | Operating Lease, Payments 12 month |
|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $731.00K 10-K · filed 2026-03-19 | |
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $778.00K 10-K · filed 2026-03-19 | |
| 2023-12-31 | $733.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $781.00K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |